{"id":"gadobenic-acid","rwe":[{"pmid":"30000512","year":"2006","title":"Gadobenate.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"41121515","year":"2025","title":"Quantitative Assessment of Liver Fibrosis: B1 Inhomogeneity-Corrected VFA T1 Mapping on Gadobenate Dimeglumine-Enhanced MRI.","finding":"","journal":"Current medical imaging","studyType":"Clinical Study"},{"pmid":"39966271","year":"2025","title":"Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions.","finding":"","journal":"European radiology experimental","studyType":"Clinical Study"},{"pmid":"39603743","year":"2024","title":"Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging.","finding":"","journal":"Radiologia","studyType":"Clinical Study"},{"pmid":"39144000","year":"2024","title":"Whole-liver histogram analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging for predicting progression in patients with cirrhosis.","finding":"","journal":"Quantitative imaging in medicine and surgery","studyType":"Clinical Study"}],"tags":[{"label":"Paramagnetic Contrast Agent","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V08CA08","category":"atc"},{"label":"Active","category":"status"},{"label":"Contrast Media","category":"pharmacology"},{"label":"Diagnostic Uses of Chemicals","category":"pharmacology"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["gadobenic acid"],"offLabel":[],"synonyms":["gadobenic acid"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"moaClass":"Magnetic Resonance Contrast Activity","modality":"Small Molecule","drugClass":"Paramagnetic Contrast Agent","explanation":"Imagine you're trying to see a small object in a dark room. Gadobenic acid helps doctors see internal structures more clearly by making them slightly brighter and more visible on imaging tests. This is because the gadolinium in the agent interacts with the magnetic field used in imaging tests, making it easier to see what's going on inside the body.","oneSentence":"Gadobenic acid works by altering the magnetic properties of surrounding tissues, allowing for clearer imaging of internal structures.","technicalDetail":"Gadobenic acid is a gadolinium-based contrast agent that works by shortening the T1 relaxation time of surrounding tissues, allowing for enhanced contrast and visualization in magnetic resonance imaging (MRI) scans."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4557","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=gadobenic%20acid","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=gadobenic acid","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:55:43.555022","biosimilars":[],"competitors":[{"drugName":"gadopentetate dimeglumine","drugSlug":"gadopentetate-dimeglumine","fdaApproval":"1988-06-02","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gadodiamide","drugSlug":"gadodiamide","fdaApproval":"1993-01-08","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gadoteridol","drugSlug":"gadoteridol","fdaApproval":"1992-11-16","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mangafodipir","drugSlug":"mangafodipir","fdaApproval":"1997-11-26","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gadoversetamide","drugSlug":"gadoversetamide","fdaApproval":"1999-12-08","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gadobutrol","drugSlug":"gadobutrol","fdaApproval":"2011-03-14","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"gadofosveset","drugSlug":"gadofosveset","fdaApproval":"2008-12-22","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gadopiclenol","drugSlug":"gadopiclenol","fdaApproval":"2022-09-21","patentExpiry":"Sep 19, 2028","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"gadobenic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"gadopentetate-dimeglumine","brandName":"gadopentetate dimeglumine","genericName":"gadopentetate dimeglumine","approvalYear":"1988","relationship":"same-class"},{"drugId":"gadodiamide","brandName":"gadodiamide","genericName":"gadodiamide","approvalYear":"1993","relationship":"same-class"},{"drugId":"gadoteridol","brandName":"gadoteridol","genericName":"gadoteridol","approvalYear":"1992","relationship":"same-class"},{"drugId":"mangafodipir","brandName":"mangafodipir","genericName":"mangafodipir","approvalYear":"1997","relationship":"same-class"},{"drugId":"gadoversetamide","brandName":"gadoversetamide","genericName":"gadoversetamide","approvalYear":"1999","relationship":"same-class"},{"drugId":"gadobutrol","brandName":"gadobutrol","genericName":"gadobutrol","approvalYear":"2011","relationship":"same-class"},{"drugId":"gadofosveset","brandName":"gadofosveset","genericName":"gadofosveset","approvalYear":"2008","relationship":"same-class"},{"drugId":"gadopiclenol","brandName":"gadopiclenol","genericName":"gadopiclenol","approvalYear":"2022","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02722525","phase":"NA","title":"Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2014-12","conditions":["Cardiovascular Injury","Prostate Carcinoma"],"enrollment":23,"completionDate":"2026-12-31"},{"nctId":"NCT01237054","phase":"PHASE2","title":"Imaging in MGUS, SMM and MM","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-10-17","conditions":["Multiple Myeloma","Smoldering Multiple Myeloma","Monoclonal Gammopathy of Undetermined Significance"],"enrollment":31,"completionDate":"2011-08-09"},{"nctId":"NCT04373564","phase":"PHASE4","title":"Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years","status":"RECRUITING","sponsor":"Guerbet","startDate":"2021-03-24","conditions":["Motor Function","Cognitive Function","Contrast Media"],"enrollment":2076,"completionDate":"2028-12-31"},{"nctId":"NCT04910425","phase":"PHASE2","title":"PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2023-06-17","conditions":["Prostate Carcinoma"],"enrollment":0,"completionDate":"2028-07"},{"nctId":"NCT05783271","phase":"NA","title":"Validity of Parametric MRI Using VIRADS","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":["Bladder Cancer"],"enrollment":58,"completionDate":"2026-12-31"},{"nctId":"NCT04879628","phase":"PHASE2","title":"Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2021-06-07","conditions":["Multiple Sclerosis"],"enrollment":129,"completionDate":"2027-08-23"},{"nctId":"NCT04973007","phase":"PHASE4","title":"Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2021-06-22","conditions":["Oligometastatic Disease","Liver Metastases","Colorectal Cancer"],"enrollment":10,"completionDate":"2025-05-08"},{"nctId":"NCT03703492","phase":"PHASE2","title":"Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-01-03","conditions":["Breast Cancer","Ductal Carcinoma in Situ - Category"],"enrollment":12,"completionDate":"2024-01-02"},{"nctId":"NCT03337594","phase":"","title":"Gadolinium Retention in Human Bone Tissue in Pediatric Patients","status":"COMPLETED","sponsor":"Donna Roberts","startDate":"2017-10-01","conditions":["Gadolinium","MultiHance","Dotarem","Magnetic Resonance Imaging","Gadolinium Retention"],"enrollment":57,"completionDate":"2024-08-31"},{"nctId":"NCT06406517","phase":"PHASE3","title":"Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-05","conditions":["Congenital Heart Disease"],"enrollment":160,"completionDate":"2025-06"},{"nctId":"NCT03588286","phase":"NA","title":"Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)","status":"RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2014-02-27","conditions":["Sudden Cardiac Death"],"enrollment":1058,"completionDate":"2029-12-06"},{"nctId":"NCT02869243","phase":"PHASE1","title":"A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients","status":"COMPLETED","sponsor":"Stemgen","startDate":"2017-07-18","conditions":["Glioblastoma"],"enrollment":15,"completionDate":"2021-06-30"},{"nctId":"NCT00375830","phase":"PHASE2","title":"Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-01","conditions":["Cancer"],"enrollment":114,"completionDate":"2019-03-14"},{"nctId":"NCT02095353","phase":"","title":"Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2014-09-01","conditions":["Central Nervous System Neoplasms"],"enrollment":6,"completionDate":"2017-03-07"},{"nctId":"NCT00415805","phase":"PHASE3","title":"Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2006-12","conditions":["Steno-occlusive Disease"],"enrollment":39,"completionDate":"2009-02"},{"nctId":"NCT03064295","phase":"","title":"Whole-Heart Myocardial Blood Flow Quantification Using MRI","status":"UNKNOWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-03-01","conditions":["Coronary Artery Disease","Coronary Microvascular Disease"],"enrollment":160,"completionDate":"2025-01-01"},{"nctId":"NCT04132843","phase":"NA","title":"Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-01-10","conditions":["Brain Neoplasm","Lymphoma","Metastatic Malignant Neoplasm in the Brain","Recurrent Malignant Brain Neoplasm"],"enrollment":6,"completionDate":"2022-09-01"},{"nctId":"NCT05292885","phase":"","title":"Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2022-03-18","conditions":["Liver Fibrosis After Liver Transplantation","Multiparameter Magnetic Resonance Imaging"],"enrollment":40,"completionDate":"2022-12-01"},{"nctId":"NCT02633501","phase":"PHASE2","title":"P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2016-06","conditions":["CNS Lesion","Blood Brain Barrier Defect"],"enrollment":312,"completionDate":"2018-01"},{"nctId":"NCT04863911","phase":"","title":"Comparative Study Between CT Arthrography and MRI Arthrography in Detection of Intra-articular Hip Pathology","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-10","conditions":["Hip Disease"],"enrollment":50,"completionDate":"2022-12"},{"nctId":"NCT03091803","phase":"","title":"QSM and Regional DCE MRI Permeability Using GOCART Technique","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2017-04-04","conditions":["Intracranial Neoplasm"],"enrollment":0,"completionDate":"2021-04-04"},{"nctId":"NCT01986868","phase":"NA","title":"Identification of Adverse Plaque Characteristics by Coronary MR Angiography","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2012-04","conditions":["Coronary Artery Disease"],"enrollment":2,"completionDate":"2018-01-24"},{"nctId":"NCT00395863","phase":"PHASE4","title":"Multihance at 3 Tesla (3T) in Brain Tumors","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2006-11","conditions":["Brain Tumor"],"enrollment":46,"completionDate":"2008-03"},{"nctId":"NCT01655290","phase":"PHASE2","title":"Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2012-08","conditions":["Subacute/Chronic Myocardial Infarction"],"enrollment":20,"completionDate":"2014-06"},{"nctId":"NCT03108378","phase":"","title":"Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2014-10","conditions":["Gadolinium Retention"],"enrollment":28,"completionDate":"2019-12"},{"nctId":"NCT04346472","phase":"","title":"Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-03-01","conditions":["Low-grade Glioma"],"enrollment":200,"completionDate":"2020-01-30"},{"nctId":"NCT02599844","phase":"","title":"Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2015-12","conditions":["Acute Kidney Injury","Chronic Kidney Disease","Hypertension"],"enrollment":0,"completionDate":"2020-02-01"},{"nctId":"NCT02933034","phase":"PHASE1,PHASE2","title":"Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury","status":"COMPLETED","sponsor":"Stanford University","startDate":"2015-04","conditions":["ISCHEMIC CARDIOMYOPATHY"],"enrollment":33,"completionDate":"2019-02-03"},{"nctId":"NCT00958464","phase":"","title":"The Effect of Perthes' Disease on Hip Cartilage","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2008-01","conditions":["Perthes' Disease"],"enrollment":20,"completionDate":"2017-06"},{"nctId":"NCT02350829","phase":"NA","title":"T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2014-02","conditions":["Cardiomyopathy"],"enrollment":65,"completionDate":"2017-08"},{"nctId":"NCT02896946","phase":"NA","title":"Diffusion MRI for Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2011-02","conditions":["Pancreatic Adenocarcinoma"],"enrollment":118,"completionDate":""},{"nctId":"NCT01211873","phase":"PHASE3","title":"Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-09","conditions":["Diagnostic Self Evaluation","Central Nervous System Diseases"],"enrollment":416,"completionDate":"2011-11"},{"nctId":"NCT03910114","phase":"","title":"Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1990-07-01","conditions":["Magnetic Resonance Imaging Contrast Agents"],"enrollment":500,"completionDate":"2019-04-01"},{"nctId":"NCT02501759","phase":"NA","title":"Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2015-05","conditions":["Health Status Unknown","Prostate Carcinoma"],"enrollment":2,"completionDate":"2017-02-10"},{"nctId":"NCT03193463","phase":"EARLY_PHASE1","title":"Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy","status":"WITHDRAWN","sponsor":"Michael Vogelbaum, MD, PhD","startDate":"2017-11-03","conditions":["Glioma"],"enrollment":0,"completionDate":"2018-11-19"},{"nctId":"NCT03147989","phase":"","title":"Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2017-05-18","conditions":["Central Nervous System Diseases","Central Nervous System Neoplasms"],"enrollment":352,"completionDate":"2018-03-16"},{"nctId":"NCT02057874","phase":"NA","title":"3-Tesla MRI Response to TACE in HCC (Liver Cancer)","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2014-02","conditions":["Adult Primary Hepatocellular Carcinoma","Advanced Adult Primary Liver Cancer","Localized Resectable Adult Primary Liver Cancer","Localized Unresectable Adult Primary Liver Cancer","Stage A Adult Primary Liver Cancer (BCLC)","Stage B Adult Primary Liver Cancer (BCLC)"],"enrollment":2,"completionDate":"2015-12-04"},{"nctId":"NCT01779869","phase":"PHASE4","title":"Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":["Ischemic Heart Disease"],"enrollment":16,"completionDate":"2015-06"},{"nctId":"NCT01988675","phase":"","title":"MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2004-08-26","conditions":["Brain Neoplasms"],"enrollment":91,"completionDate":"2014-06-03"},{"nctId":"NCT01992718","phase":"EARLY_PHASE1","title":"What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2013-11","conditions":["Uterine Bleeding","Uterine Fibroids","Adenomyosis"],"enrollment":49,"completionDate":"2018-03"},{"nctId":"NCT02092428","phase":"PHASE1","title":"Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-04","conditions":["Coronary Artery Disease"],"enrollment":333,"completionDate":"2017-03-01"},{"nctId":"NCT01671579","phase":"NA","title":"Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease","status":"TERMINATED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2012-03","conditions":["Crohn Disease"],"enrollment":33,"completionDate":"2017-08"},{"nctId":"NCT01710254","phase":"PHASE2","title":"Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-01","conditions":["Atrial Fibrillation","Coronary Artery Disease"],"enrollment":30,"completionDate":"2016-10"},{"nctId":"NCT00373152","phase":"PHASE2","title":"MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer","status":"WITHDRAWN","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-03","conditions":["Breast Cancer"],"enrollment":0,"completionDate":"2010-06"},{"nctId":"NCT00539253","phase":"NA","title":"Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2007-09","conditions":["Hepatocellular Carcinoma"],"enrollment":45,"completionDate":"2013-12"},{"nctId":"NCT02597543","phase":"PHASE4","title":"Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction","status":"COMPLETED","sponsor":"Paul Kim","startDate":"2015-11","conditions":["Heart Transplant","Acute Graft Rejection","Chronic Graft Rejection"],"enrollment":14,"completionDate":"2016-06-30"},{"nctId":"NCT00033397","phase":"","title":"Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2002-02","conditions":["Breast Cancer"],"enrollment":360,"completionDate":"2012-05-01"},{"nctId":"NCT00537056","phase":"NA","title":"Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-10","conditions":["Kidney Neoplasms","Carcinoma, Renal Cell","Kidney (Renal Cell) Cancer"],"enrollment":17,"completionDate":"2012-04"},{"nctId":"NCT01996527","phase":"EARLY_PHASE1","title":"3T MRI Biomarkers of Glioma Treatment Response","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2012-05","conditions":["Adult Anaplastic Astrocytoma","Adult Anaplastic Ependymoma","Adult Anaplastic Oligodendroglioma","Adult Giant Cell Glioblastoma","Adult Glioblastoma","Adult Gliosarcoma","Recurrent Adult Brain Tumor"],"enrollment":7,"completionDate":"2016-01-01"},{"nctId":"NCT02278510","phase":"EARLY_PHASE1","title":"Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma","status":"COMPLETED","sponsor":"Michael Vogelbaum, MD, PhD","startDate":"2014-12-09","conditions":["Malignant Glioma","WHO Grade III or IV Recurrent Glioma"],"enrollment":3,"completionDate":"2015-11-10"},{"nctId":"NCT02967380","phase":"NA","title":"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2011-12-14","conditions":["Adult Anaplastic (Malignant) Meningioma","Adult Anaplastic Astrocytoma","Adult Anaplastic Ependymoma","Adult Anaplastic Oligodendroglioma","Adult Brain Stem Glioma","Adult Choroid Plexus Neoplasm","Adult Diffuse Astrocytoma","Adult Ependymoblastoma","Adult Ependymoma","Adult Giant Cell Glioblastoma","Adult Glioblastoma","Adult Gliosarcoma","Adult Grade II Meningioma","Adult Medulloblastoma","Adult Mixed Glioma","Adult Oligodendroglioma","Adult Papillary Meningioma","Adult Pineal Gland Astrocytoma","Adult Pineoblastoma","Adult Primary Melanocytic Lesion of Meninges","Adult Supratentorial Primitive Neuroectodermal Tumor","Malignant Adult Intracranial Hemangiopericytoma","Metastatic Malignant Neoplasm in the Brain","Multiple Sclerosis","Recurrent Adult Brain Neoplasm"],"enrollment":14,"completionDate":"2015-10-14"},{"nctId":"NCT00019604","phase":"PHASE2","title":"Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1998-08","conditions":["Liver Cancer","Metastatic Cancer","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":44,"completionDate":"2009-01"},{"nctId":"NCT02226666","phase":"","title":"Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2013-08","conditions":["Liver Tumor"],"enrollment":107,"completionDate":"2015-12"},{"nctId":"NCT02070380","phase":"PHASE4","title":"Crossover Comparison of MultiHance and Dotarem","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2014-02","conditions":["Brain Disease"],"enrollment":179,"completionDate":"2015-03"},{"nctId":"NCT01989195","phase":"PHASE1,PHASE2","title":"Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-05","conditions":["ISCHEMIC CARDIOMYOPATHY"],"enrollment":6,"completionDate":"2013-06"},{"nctId":"NCT03000036","phase":"NA","title":"Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2012-07","conditions":["Breast Cancer Female","Doxorubicin Induced Cardiomyopathy"],"enrollment":27,"completionDate":"2016-07"},{"nctId":"NCT02992847","phase":"","title":"Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2017-01","conditions":["Multiple Sclerosis"],"enrollment":160,"completionDate":"2017-07"},{"nctId":"NCT02371798","phase":"NA","title":"Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2015-02","conditions":["Meniere Disease"],"enrollment":0,"completionDate":"2016-11"},{"nctId":"NCT00577915","phase":"NA","title":"Breast MRI Spectroscopy","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-05","conditions":["Suspicion of, or Known Breast Cancer"],"enrollment":150,"completionDate":"2016-06"},{"nctId":"NCT02895633","phase":"NA","title":"Osteoarticular Tumor Characterization by Advanced Imaging","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2009-11","conditions":["Bone Tumor","Soft Tissue Tumor"],"enrollment":1090,"completionDate":"2020-11"},{"nctId":"NCT02291822","phase":"","title":"Retrospective Study of MRI in Pediatric Patients","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2014-11","conditions":["Central Nervous System Disease","Central Nervous System Neoplasms"],"enrollment":90,"completionDate":"2015-12"},{"nctId":"NCT02400840","phase":"NA","title":"Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging","status":"WITHDRAWN","sponsor":"University Hospital, Rouen","startDate":"2015-01","conditions":["Cardiac Graft"],"enrollment":0,"completionDate":"2018-05"},{"nctId":"NCT01047059","phase":"PHASE2","title":"Molecular Imaging With Erlotinib and Bevacizumab","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2010-01","conditions":["Non-Small-Cell Lung Carcinoma"],"enrollment":40,"completionDate":"2016-05"},{"nctId":"NCT02080312","phase":"NA","title":"Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2012-01","conditions":["Meniere's Disease"],"enrollment":6,"completionDate":"2013-12"},{"nctId":"NCT01956409","phase":"PHASE4","title":"Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-09","conditions":["Breast Cancer Diagnosis","Positron Emission Tomography","Magnetic Resonance Imaging"],"enrollment":80,"completionDate":"2017-03"},{"nctId":"NCT00751920","phase":"PHASE3","title":"Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2008-08","conditions":["Metastatic Pulmonary Nodules"],"enrollment":1,"completionDate":"2010-12"},{"nctId":"NCT00937391","phase":"PHASE3","title":"Contrast-enhanced MRI in Children 2 Months to <2 Years","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":["Magnetic Resonance Imaging"],"enrollment":54,"completionDate":"2010-09"},{"nctId":"NCT02074293","phase":"PHASE1,PHASE2","title":"ASIS for Botox in Cervical Dystonia","status":"UNKNOWN","sponsor":"li nguyen","startDate":"2016-01","conditions":["Cervical Dystonia Adults ,","Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus."],"enrollment":60,"completionDate":"2017-06"},{"nctId":"NCT02074150","phase":"PHASE1,PHASE2","title":"ASIS for Botox in Upper Limb Spasticity","status":"UNKNOWN","sponsor":"li nguyen","startDate":"2016-01","conditions":["Upper Limb Spasticity Unilaterally in Adults With History of Stroke","Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors."],"enrollment":60,"completionDate":"2017-06"},{"nctId":"NCT02112097","phase":"PHASE1,PHASE2","title":"ASIS for Enbrel in Plaque Psoriasis","status":"UNKNOWN","sponsor":"ASIS Corporation","startDate":"2016-01","conditions":["Plaque Psoriasis."],"enrollment":60,"completionDate":"2017-06"},{"nctId":"NCT02123615","phase":"PHASE1,PHASE2","title":"ASIS for GAMMAGARD in Primary Immunodeficiency","status":"UNKNOWN","sponsor":"ASIS Corporation","startDate":"2016-01","conditions":["Primary Immunodeficiency"],"enrollment":60,"completionDate":"2016-06"},{"nctId":"NCT02074163","phase":"PHASE1,PHASE2","title":"ASIS for Botox in Chronic Migraine","status":"UNKNOWN","sponsor":"ASIS Corporation","startDate":"2016-01","conditions":["Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer."],"enrollment":60,"completionDate":"2017-06"},{"nctId":"NCT00395460","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-09","conditions":["Central Nervous System Diseases"],"enrollment":147,"completionDate":"2007-04"},{"nctId":"NCT00309075","phase":"PHASE3","title":"Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-12","conditions":["Stenosis"],"enrollment":126,"completionDate":"2004-11"},{"nctId":"NCT00310609","phase":"PHASE3","title":"Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-12","conditions":["Cardiovascular Abnormalities"],"enrollment":123,"completionDate":"2004-10"},{"nctId":"NCT00310596","phase":"PHASE1","title":"Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":["Healthy"],"enrollment":71,"completionDate":"2004-03"},{"nctId":"NCT01050829","phase":"PHASE3","title":"Gadobutrol Magnevist-controlled Body Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":["Magnetic Resonance Imaging"],"enrollment":370,"completionDate":"2011-04"},{"nctId":"NCT00185276","phase":"PHASE3","title":"Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-03","conditions":["Peripheral Vascular Disease"],"enrollment":365,"completionDate":"2004-08"},{"nctId":"NCT00310557","phase":"PHASE3","title":"Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-12","conditions":["Renal Artery Stenosis"],"enrollment":116,"completionDate":"2004-12"},{"nctId":"NCT00310544","phase":"PHASE2","title":"Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-03","conditions":["Myocardial Infarction"],"enrollment":73,"completionDate":"2006-09"},{"nctId":"NCT00681551","phase":"PHASE3","title":"Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-02","conditions":["Brain Neoplasms"],"enrollment":45,"completionDate":"2004-03"},{"nctId":"NCT01836055","phase":"","title":"Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist","status":"TERMINATED","sponsor":"Wayne State University","startDate":"2012-01","conditions":["Multiple Sclerosis"],"enrollment":19,"completionDate":"2014-02"},{"nctId":"NCT00600951","phase":"","title":"Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2008-01","conditions":["Renal Insufficiency"],"enrollment":366,"completionDate":"2013-08"},{"nctId":"NCT01234870","phase":"PHASE2,PHASE3","title":"Comprehensive Evaluation of Ischemic Heart Disease Using MRI","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2010-06","conditions":["Heart Disease, Ischemic","Atherosclerosis, Coronary"],"enrollment":40,"completionDate":"2012-01"},{"nctId":"NCT00744939","phase":"","title":"Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-11","conditions":["Fibrosis","Kidney Failure","Renal Insufficiency"],"enrollment":168,"completionDate":"2013-11"},{"nctId":"NCT02175069","phase":"PHASE4","title":"Magnetic Resonance Imaging of Interscalene Plexus Block","status":"COMPLETED","sponsor":"Paracelsus Medical University","startDate":"2013-12","conditions":["Disorder of Shoulder"],"enrollment":30,"completionDate":"2014-07"},{"nctId":"NCT00060008","phase":"NA","title":"Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2002-04","conditions":["Neurofibromatosis Type 1","Precancerous Condition"],"enrollment":18,"completionDate":"2011-05"},{"nctId":"NCT01416740","phase":"NA","title":"A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2009-12","conditions":["Shoulder Pain"],"enrollment":0,"completionDate":"2012-09"},{"nctId":"NCT00395733","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-10","conditions":["Vascular Diseases"],"enrollment":83,"completionDate":"2007-10"},{"nctId":"NCT00652418","phase":"PHASE2","title":"Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-07","conditions":["Magnetic Resonance Angiography","Peripheral Vascular Diseases","Peripheral Arterial Diseases"],"enrollment":12,"completionDate":"2004-10"},{"nctId":"NCT00043017","phase":"PHASE2","title":"Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer","status":"COMPLETED","sponsor":"American College of Radiology Imaging Network","startDate":"2002-05","conditions":["Breast Cancer"],"enrollment":356,"completionDate":"2011-03"},{"nctId":"NCT00004936","phase":"NA","title":"MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients","status":"COMPLETED","sponsor":"American College of Radiology Imaging Network","startDate":"2000-04","conditions":["Cervical Cancer"],"enrollment":0,"completionDate":"2002-10"},{"nctId":"NCT00005790","phase":"NA","title":"Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"1996-04","conditions":["Brain and Central Nervous System Tumors"],"enrollment":0,"completionDate":"1999-05"},{"nctId":"NCT00907530","phase":"PHASE4","title":"Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2009-09","conditions":["Brain Lesions"],"enrollment":121,"completionDate":"2011-07"},{"nctId":"NCT01260636","phase":"PHASE3","title":"Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2009-09","conditions":["Carotid, Aortic, Renal or Peripheral Artery Disease"],"enrollment":120,"completionDate":"2011-12"},{"nctId":"NCT01376739","phase":"","title":"Magnevist Post-marketing Surveillance in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":["Diagnostic Imaging"],"enrollment":2051,"completionDate":"2010-06"},{"nctId":"NCT00323310","phase":"PHASE3","title":"Safety and Efficacy of MultiHance in Pediatric Patients","status":"TERMINATED","sponsor":"Bracco Diagnostics, Inc","startDate":"2006-04","conditions":["Central Nervous System Diseases"],"enrollment":92,"completionDate":"2008-09"},{"nctId":"NCT00486473","phase":"PHASE3","title":"Multihance Versus Magnevist in Breast MRI","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2007-07","conditions":["Breast Cancer"],"enrollment":130,"completionDate":"2009-12"},{"nctId":"NCT00977093","phase":"PHASE3","title":"A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Amersham Buchler, GmbH & Co KG","startDate":"2003-07","conditions":["Coronary Artery Disease"],"enrollment":533,"completionDate":"2004-06"},{"nctId":"NCT00408083","phase":"PHASE3","title":"Crossover Study With MultiHance vs a Comparator for Peripheral MRA","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2006-12","conditions":["Peripheral Vascular Disease"],"enrollment":100,"completionDate":"2008-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"007716","UNII":"15G12L5X8K","INN_ID":"6688","UMLSCUI":"C0246154","ChEMBL_ID":"CHEMBL1200571","KEGG_DRUG":"D08018","DRUGBANK_ID":"DB00743","PUBCHEM_CID":"24838350","SNOMEDCT_US":"710810006","MESH_SUPPLEMENTAL_RECORD_UI":"C064572"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":25,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V08CA08","allCodes":["V08CA08"]},"biosimilarFilings":[],"recentPublications":[{"date":"2006","pmid":"30000512","title":"Gadobenate.","journal":""},{"date":"2025 Oct 20","pmid":"41121515","title":"Quantitative Assessment of Liver Fibrosis: B1 Inhomogeneity-Corrected VFA T1 Mapping on Gadobenate Dimeglumine-Enhanced MRI.","journal":"Current medical imaging"},{"date":"2025 Feb 18","pmid":"39966271","title":"Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions.","journal":"European radiology experimental"},{"date":"2024 Oct","pmid":"39603743","title":"Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging.","journal":"Radiologia"},{"date":"2024 Aug 1","pmid":"39144000","title":"Whole-liver histogram analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging for predicting progression in patients with cirrhosis.","journal":"Quantitative imaging in medicine and surgery"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"gadobenic acid","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Gadobenic acid is a small molecule used as a diagnostic agent in magnetic resonance imaging (MRI). It is a gadolinium-based contrast medium, specifically a complex of gadolinium with the ligand BOPTA, used to enhance imaging in various conditions such as coronary artery disease and CNS lesions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}